MICA and cancer: These drugs also upregulate the expression of MHC class I polypeptide-related sequence A (MICA) and heat shock protein 70 (HSP70) on cancer cells through the phosphatidylinositide 3-kinase/protein kinase B pathway leading to NK cell activation (316).